These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 22575310)

  • 1. Ventricular arrhythmias in the absence of structural heart disease.
    Prystowsky EN; Padanilam BJ; Joshi S; Fogel RI
    J Am Coll Cardiol; 2012 May; 59(20):1733-44. PubMed ID: 22575310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of ventricular arrhythmias.
    Aronow WS
    Minerva Cardioangiol; 2010 Dec; 58(6):657-76. PubMed ID: 21135807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outflow tract ventricular arrhythmias: An update.
    Lerman BB
    Trends Cardiovasc Med; 2015 Aug; 25(6):550-8. PubMed ID: 25846938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical management of ventricular tachycardia.
    Pellegrini CN; Scheinman MM
    Curr Probl Cardiol; 2010 Sep; 35(9):453-504. PubMed ID: 20887902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrhythmogenic hereditary syndromes: Brugada Syndrome, long QT syndrome, short QT syndrome and CPVT.
    Schimpf R; Veltmann C; Wolpert C; Borggrefe M
    Minerva Cardioangiol; 2010 Dec; 58(6):623-36. PubMed ID: 21135804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy in inherited and acquired ventricular arrhythmia in structurally normal adult hearts.
    Ortmans S; Daval C; Aguilar M; Compagno P; Cadrin-Tourigny J; Dyrda K; Rivard L; Tadros R
    Expert Opin Pharmacother; 2019 Dec; 20(17):2101-2114. PubMed ID: 31566420
    [No Abstract]   [Full Text] [Related]  

  • 7. Sudden death and ion channel disease: pathophysiology and implications for management.
    Bastiaenen R; Behr ER
    Heart; 2011 Sep; 97(17):1365-72. PubMed ID: 21685181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic basis of malignant channelopathies and ventricular fibrillation in the structurally normal heart.
    Hofman N; van Lochem LT; Wilde AA
    Future Cardiol; 2010 May; 6(3):395-408. PubMed ID: 20462344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
    Oreto G; Corrado D; Delise P; Fedele F; Gaita F; Gentile F; Giustetto C; Michelucci A; Padeletti L; Priori S
    G Ital Cardiol (Rome); 2010 Nov; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular tachycardia in structurally normal hearts: recognition and management.
    Nathani P; Shetty S; Lokhandwala Y
    J Assoc Physicians India; 2007 Apr; 55 Suppl():33-8. PubMed ID: 18368865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and initial characteristics of pilsicainide-induced ventricular arrhythmias in patients with Brugada syndrome.
    Chinushi M; Komura S; Izumi D; Furushima H; Tanabe Y; Washizuka T; Aizawa Y
    Pacing Clin Electrophysiol; 2007 May; 30(5):662-71. PubMed ID: 17461877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes.
    Haïssaguerre M; Extramiana F; Hocini M; Cauchemez B; Jaïs P; Cabrera JA; Farré J; Leenhardt A; Sanders P; Scavée C; Hsu LF; Weerasooriya R; Shah DC; Frank R; Maury P; Delay M; Garrigue S; Clémenty J
    Circulation; 2003 Aug; 108(8):925-8. PubMed ID: 12925452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of ventricular arrhythmias in the elderly.
    Aronow WS
    Cardiol Rev; 2009; 17(3):136-46. PubMed ID: 19384088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
    Ohnishi S; Kasanuki H
    J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments.
    van der Werf C; Zwinderman AH; Wilde AA
    Europace; 2012 Feb; 14(2):175-83. PubMed ID: 21893508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification of spatial dispersion of repolarization underlies sudden cardiac death associated with catecholaminergic polymorphic VT, long QT, short QT and Brugada syndromes.
    Antzelevitch C; Oliva A
    J Intern Med; 2006 Jan; 259(1):48-58. PubMed ID: 16336513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sudden cardiac death and genetic ion channelopathies: long QT, Brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation.
    Napolitano C; Bloise R; Monteforte N; Priori SG
    Circulation; 2012 Apr; 125(16):2027-34. PubMed ID: 22529064
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sudden cardiac death and inherited repolarization disorders].
    Gościńska K; Sredniawa B; Pasyk S
    Przegl Lek; 2002; 59(7):523-6. PubMed ID: 12516242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sudden cardiac death: what is inside our genes?
    Sarkozy A; Brugada P
    Can J Cardiol; 2005 Oct; 21(12):1099-110. PubMed ID: 16234896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and mechanistic issues in early repolarization of normal variants and lethal arrhythmia syndromes.
    Benito B; Guasch E; Rivard L; Nattel S
    J Am Coll Cardiol; 2010 Oct; 56(15):1177-86. PubMed ID: 20883924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.